# Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia

> **NCT07689162** · PHASE2 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 45 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Standard Bupivacaine
- **DRUG:** Liposomal Bupivacaine

## Key facts

- **NCT ID:** NCT07689162
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-07
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07689162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07689162, "Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07689162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*